id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-337896-mct29erg	Kornbluth, Asher	Management of Inflammatory Bowel Disease and COVID-19 in New York City 2020: The Epicenter of IBD in the First Epicenter of the Global Pandemic	2020-09-03		.txt	text/plain	5111	212	55	A number of the major GI societies, the Crohn's & Colitis Foundation, 3 British Society of Gastroenterology, 4 European Crohn's and Colitis Organization, 5 The American Gastroenterology Association, 6 and the International Organization for the Study of Inflammatory Bowel Disease (IOIBD) 7 have published guidelines regarding treating the IBD patient with SARS-CoV-2 and COVID-19. 8 The key features are that the patient without proven or suspected SARS-CoV-2 should continue on their current medications with aggressive attempts to reduce steroid usage because this is the only single agent that has been associated with increased poor outcomes with COVID-19, defined in the SECURE registry as a composite score of hospitalization, intubation, or death. 14 We are now participating in the development of a database that will follow patients after clearance of the SARS-CoV-2 virus to determine the courses and outcomes of the IBD and of any sequelae or recurrence of COVID-19 after any drug therapy has been suspended.	./cache/cord-337896-mct29erg.txt	./txt/cord-337896-mct29erg.txt